Cargando…
Differential Regulation of MMP‐9 and TIMP‐2 Expression in Malignant Melanoma Developed in Metallothionein/RET Transgenic Mice
We recently established a metallothionein‐I(MT)/RET transgenic mouse line in which skin melanosis, benign melanocytic tumor and malignant melanoma develop stepwise. Malignant melanoma cells but not benign melanocytic tumor cells had metastatic ability in transgenic mice. In the present study, we inv...
Autores principales: | Asai, Masami, Kato, Masashi, Asai, Naoya, Iwashita, Toshihide, Murakami, Hideki, Kawai, Kumi, Nakashima, Izumi, Takahashi1, Masahide |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925989/ https://www.ncbi.nlm.nih.gov/pubmed/10076570 http://dx.doi.org/10.1111/j.1349-7006.1999.tb00670.x |
Ejemplares similares
-
Roles of the RET Proto-oncogene in Cancer and Development
por: Takahashi, Masahide, et al.
Publicado: (2020) -
Neuroblastoma in a transgenic mouse carrying a metallothionein/ret fusion gene.
por: Iwamoto, T., et al.
Publicado: (1993) -
Mapping of Melanoma Modifier Loci in RET Transgenic Mice
por: Dragani, Tommaso A., et al.
Publicado: (2000) -
Expression of RET finger protein predicts chemoresistance in epithelial ovarian cancer
por: Horio, Maiko, et al.
Publicado: (2012) -
Loss-of-function mutation of c-Ret causes cerebellar hypoplasia in mice with Hirschsprung disease and Down's syndrome
por: Ohgami, Nobutaka, et al.
Publicado: (2021)